Burkholderia pseudomallei Class A β-Lactamase Mutations That Confer Selective Resistance against Ceftazidime or Clavulanic Acid Inhibition
Authors:
- 1 July 2003
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 47 (7) , 2082-2087
Abstract
Burkholderia pseudomallei , the causative agent of melioidosis, is inherently resistant to a variety of antibiotics including aminoglycosides, macrolides, polymyxins, and β-lactam antibiotics. Despite resistance to many β-lactams, ceftazidime and β-lactamase inhibitor-β-lactam combinations are commonly used for treatment of melioidosis. Here, we examine the enzyme kinetics of β-lactamase isolated from mutants resistant to ceftazidime and clavulanic acid inhibition and describe specific mutations within conserved motifs of the β-lactamase enzyme which account for these resistance patterns. Sequence analysis of regions flanking the B. pseudomallei penA gene revealed a putative regulator gene located downstream of penA . We have cloned and sequenced the penA gene from B. mallei and found it to be identical to penA from B. pseudomallei .Keywords
This publication has 19 references indexed in Scilit:
- Cloning and Expression of Class A β-Lactamase Gene blaA BPS in Burkholderia pseudomalleiAntimicrobial Agents and Chemotherapy, 2002
- CTX-M-Type Extended-Spectrum β-Lactamase That Hydrolyzes Ceftazidime through a Single Amino Acid Substitution in the Omega LoopAntimicrobial Agents and Chemotherapy, 2001
- Detection of Bacterial Virulence Genes by Subtractive Hybridization: Identification of Capsular Polysaccharide of Burkholderia pseudomallei as a Major Virulence DeterminantInfection and Immunity, 2001
- A Comparison of Chloramphenicol, Trimethoprim‐Sulfamethoxazole, and Doxycycline with Doxycycline Alone as Maintenance Therapy for MelioidosisClinical Infectious Diseases, 1999
- Note: Burkholderia thailandensis sp. nov., a Burkholderia pseudomallei-like speciesInternational Journal of Systematic and Evolutionary Microbiology, 1998
- CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choiceNucleic Acids Research, 1994
- Ceftazidime vs. Amoxicillin/Clavulanate in the Treatment of Severe MelioidosisClinical Infectious Diseases, 1994
- Development of resistance to ceftazidime and co-amoxiclav in Pseudomonas psemdomalleiJournal of Antimicrobial Chemotherapy, 1991
- Pseudomonas pseudomallei resistance to beta-lactam antibiotics due to alterations in the chromosomally encoded beta-lactamaseAntimicrobial Agents and Chemotherapy, 1991
- β-Lactamase of Pseudomonas pseudomallei and its contribution to antibiotic resistanceJournal of Antimicrobial Chemotherapy, 1987